Skip to main content
SpringerLink
Log in

Maligne Erkrankungen bei chronischer Niereninsuffizienz

  • Chapter
  • First Online:
Book cover Onko-Nephrologie

  • 633 Accesses

Zusammenfassung

Die chronische und terminale Niereninsuffizienz ist mit einem Anstieg der Tumorinzidenz assoziiert. Die Patienten erkranken häufig an Tumoren des Urogenitaltraktes, insbesondere an Nierenzellkarzinomen. Ein Screening analog zur gesunden Normalbevölkerung scheint nur für Patienten mit langer Lebenserwartung vorteilhaft zu sein.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Aapro M et al (2018) Erythropoiesis-stimulating agents in the management of anemia in chronic kidney disease or cancer: a historical perspective. Front Pharmacol 9:1498

    Article  CAS  Google Scholar 

  • Akmal M et al (1994) The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy. Clin Nephrol 42(3):198–202

    CAS  PubMed  Google Scholar 

  • Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF) (2015) D.K.e.V.D.u. and D.K. (DKH). S. 3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung. https://www.dgpalliativmedizin.de/images/stories/LL_Palliativmedizin_Kurzversion_1.1.pdf

  • Bini EJ, Kinkhabwala A, Goldfarb DS (2006) Predictive value of a positive fecal occult blood test increases as the severity of CKD worsens. Am J Kidney Dis 48(4):580–586

    Article  Google Scholar 

  • Butler AM et al (2015) Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996–2009. Am J Kidney Dis 65(5):763–772

    Article  Google Scholar 

  • Castellanos M et al (2006) Increased breast calcifications in women with ESRD on dialysis: implications for breast cancer screening. Am J Kidney Dis 48(2):301–306

    Article  Google Scholar 

  • Cohen LM et al (2000) Dying well after discontinuing the life-support treatment of dialysis. Arch Intern Med 160(16):2513–2518

    Article  CAS  Google Scholar 

  • Cohen EP et al (2015) Onco-nephrology: core curriculum 2015. Am J Kidney Dis 66(5):869–883

    Article  Google Scholar 

  • ConstanzeRémi STS, Voltz R, Pralong A, Follmann M, Bausewein C (2016) Empfehlungen zur Arzneimitteltherapie in der S. 3-Leitlinie Palliativmedizin. Arzneimitteltherapie 34. Jahrgang 5:155–162

    Google Scholar 

  • Davison SN et al (2015) Executive summary of the KDIGO controversies conference on supportive care in chronic kidney disease: developing a roadmap to improving quality care. Kidney Int 88(3):447–459

    Article  Google Scholar 

  • Dean M (2004) Opioids in renal failure and dialysis patients. J Pain Symptom Manage 28(5):497–504

    Article  CAS  Google Scholar 

  • Drueke TB, Parfrey PS (2012) Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s). Kidney Int 82(9):952–960

    Article  Google Scholar 

  • Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy. NICE guidance 2014. https://www.nice.org.uk/guidance/ta323/resources/erythropoiesisstimulating-agents-epoetin-and-darbepoetin-for-treating-anaemia-in-people-with-cancer-having-chemotherapy-pdf-82602485230021

  • ESUR. Leitlinie zur Kontrastmittelgabe. http://www.esur.org/guidelines/de/

  • Fallon M et al (2018) Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 29(Supplement_4):iv166–iv191

    Article  CAS  Google Scholar 

  • Grobner T (2006) Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21(4):1104–1108

    Article  CAS  Google Scholar 

  • Grooterhorst P (2014) Strahlenrisiken. Prakt Kardiol J Fax 17(Jahrgang 2014) Nr. XX

    Google Scholar 

  • Inker LA et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735

    Article  Google Scholar 

  • Inoue H et al (2007) Somatic mutations of the von Hippel-Lindau disease gene in renal carcinomas occurring in patients with long-term dialysis. Nephrol Dial Transplant 22(7):2052–2055

    Article  CAS  Google Scholar 

  • Joffe P, Thomsen HS, Meusel M (1998) Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 5(7):491–502

    Article  CAS  Google Scholar 

  • Kidney Disease: Improving Global Outcomes Transplant Work, G (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transpl 9(3):1–155

    Google Scholar 

  • Kinsella SM et al (2010) Maintenance hemodialysis patients have high cumulative radiation exposure. Kidney Int 78(8):789–793

    Article  Google Scholar 

  • Kondo T et al (2018) Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: central pathology results according to the 2016 WHO classification in a multi-institutional study. Pathol Int 68(10):543–549

    Article  Google Scholar 

  • Maisonneuve P et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354(9173):93–99

    Article  CAS  Google Scholar 

  • Mikhail A et al (2017) Renal association clinical practice guideline on anaemia of chronic kidney disease. BMC Nephrol 18(1):345

    Article  Google Scholar 

  • Murashima M et al (2008) Removal of gadolinium by peritoneal dialysis. Clin Nephrol 69(5):368–372

    Article  CAS  Google Scholar 

  • Murtagh FE et al (2016) Supportive care: comprehensive conservative care in end-stage kidney disease. Clin J Am Soc Nephrol 11(10):1909–1914

    Article  Google Scholar 

  • Nijssen EC et al (2017) Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet 389(10076):1312–1322

    Article  Google Scholar 

  • Palevsky PM et al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61(5):649–672

    Article  Google Scholar 

  • Palliativmedizin DGf. Definitionen zur Hospiz- und Palliativversorgung 2019. https://www.dgpalliativmedizin.de/images/DGP_GLOSSAR.pdf

  • PalliativVerband DH-u ADVANCE CARE PLANNING (ACP) in stationären Pflegeeinrichtungen. Eine Einführung auf Grundlage des Hospiz- und Palliativgesetzes. https://www.dhpv.de/tl_files/public/Service/Broschueren/Handreichung_ACP.pdf

  • Pannu N et al (2006) Prophylaxis strategies for contrast-induced nephropathy. JAMA 295(23):2765–2779

    Article  CAS  Google Scholar 

  • Perazella MA (2007) Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link? Clin J Am Soc Nephrol 2(2):200–202

    Article  CAS  Google Scholar 

  • Pfeffer MA et al (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361(21):2019–2032

    Article  Google Scholar 

  • Rizzo JD et al (2010) American society of hematology/American society of clinical oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 116(20):4045–4059

    Article  CAS  Google Scholar 

  • Satish KT, M.V.E.R., MD (2013) Papillary renal cell carcinoma. https://ebooks.amirsys.com/EbookAdvantageMain.jsp?rc=false#3

  • Schindler R et al (2001) Removal of contrast media by different extracorporeal treatments. Nephrol Dial Transplant 16(7):1471–1474

    Article  CAS  Google Scholar 

  • Stengel B (2010) Chronic kidney disease and cancer: a troubling connection. J Nephrol 23(3):253–262

    PubMed  PubMed Central  Google Scholar 

  • Stewart JH et al (2009) The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant 24(10):3225–3231

    Article  Google Scholar 

  • Tarhan F et al (2007) Effect of hemodialysis on serum complexed prostate-specific antigen levels. Scand J Urol Nephrol 41(5):382–386

    Article  CAS  Google Scholar 

  • Thomsen HS, R. European Society of Urogenital (2007) ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 17(10):2692–2696

    Google Scholar 

  • Tickoo SK et al (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30(2):141–153

    Article  Google Scholar 

  • Upadhyay C et al (2014) Measuring pain in patients undergoing hemodialysis: a review of pain assessment tools. Clin Kidney J 7(4):367–372

    Article  Google Scholar 

  • Walter LC et al (2006) Targeting screening mammography according to life expectancy among women undergoing dialysis. Arch Intern Med 166(11):1203–1208

    Article  Google Scholar 

  • Weisbord SD et al (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 378(7):603–614

    Article  CAS  Google Scholar 

  • WHO. WHO’s cancer pain ladder for adults. https://www.who.int/cancer/palliative/painladder/en/

  • Wong G et al (2009) Association of CKD and cancer risk in older people. J Am Soc Nephrol 20(6):1341–1350

    Article  CAS  Google Scholar 

  • Younathan CM et al (1994) Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. AJR Am J Roentgenol 163(4):969–971

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrologie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland

    Susanne Delecluse

Authors
  1. Susanne Delecluse
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susanne Delecluse .

Editor information

Editors and Affiliations

  1. Nationales Zentrum für Tumorerkrankungen, Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany

    Dirk Jäger

  2. Nephrologie, Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany

    Martin Zeier

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Delecluse, S. (2020). Maligne Erkrankungen bei chronischer Niereninsuffizienz. In: Jäger, D., Zeier, M. (eds) Onko-Nephrologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59911-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-59911-2_23

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-59910-5

  • Online ISBN: 978-3-662-59911-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation